
### [MONDO:0003225](http://purl.obolibrary.org/obo/MONDO_0003225)
**Label:** bone marrow disease

**Subclasses:** [MONDO:0019438](http://purl.obolibrary.org/obo/MONDO_0019438) (AL amyloidosis), [MONDO:0011173](http://purl.obolibrary.org/obo/MONDO_0011173) (thrombocythemia 2), [MONDO:0013794](http://purl.obolibrary.org/obo/MONDO_0013794) (thrombocythemia 3), [MONDO:0009692](http://purl.obolibrary.org/obo/MONDO_0009692) (primary myelofibrosis), [MONDO:0009693](http://purl.obolibrary.org/obo/MONDO_0009693) (multiple myeloma), [MONDO:0016540](http://purl.obolibrary.org/obo/MONDO_0016540) (congenital secondary polycythemia), [MONDO:0019457](http://purl.obolibrary.org/obo/MONDO_0019457) (Therapy related acute myeloid leukemia and myelodysplastic syndrome), [MONDO:0019454](http://purl.obolibrary.org/obo/MONDO_0019454) (refractory anemia with excess blasts), [MONDO:0016541](http://purl.obolibrary.org/obo/MONDO_0016541) (acquired secondary polycythemia), [MONDO:0019111](http://purl.obolibrary.org/obo/MONDO_0019111) (familial thrombocytosis), [MONDO:0019452](http://purl.obolibrary.org/obo/MONDO_0019452) (chronic myeloproliferative disease, unclassifiable), [MONDO:0015691](http://purl.obolibrary.org/obo/MONDO_0015691) (hypereosinophilic syndrome), [MONDO:0005029](http://purl.obolibrary.org/obo/MONDO_0005029) (essential thrombocythemia), [MONDO:0011996](http://purl.obolibrary.org/obo/MONDO_0011996) (chronic myelogenous leukemia), [MONDO:0007243](http://purl.obolibrary.org/obo/MONDO_0007243) (Burkitts lymphoma), [MONDO:0017834](http://purl.obolibrary.org/obo/MONDO_0017834) (secondary hypereosinophilic syndrome), [MONDO:0011118](http://purl.obolibrary.org/obo/MONDO_0011118) (bilineal acute myeloid leukemia), [MONDO:0017858](http://purl.obolibrary.org/obo/MONDO_0017858) (acute erythroid leukemia), [MONDO:0016599](http://purl.obolibrary.org/obo/MONDO_0016599) (autosomal dominant secondary polycythemia), [MONDO:0018874](http://purl.obolibrary.org/obo/MONDO_0018874) (acute myeloid leukemia), [MONDO:0018872](http://purl.obolibrary.org/obo/MONDO_0018872) (acute megakaryoblastic leukemia), [MONDO:0020078](http://purl.obolibrary.org/obo/MONDO_0020078) (acute myeloid leukemia with recurrent genetic anomaly), [MONDO:0020331](http://purl.obolibrary.org/obo/MONDO_0020331) (indolent systemic mastocytosis), [MONDO:0004948](http://purl.obolibrary.org/obo/MONDO_0004948) (chronic lymphocytic leukemia), [MONDO:0008554](http://purl.obolibrary.org/obo/MONDO_0008554) (thrombocythemia 1), [MONDO:0020311](http://purl.obolibrary.org/obo/MONDO_0020311) (chronic myelomonocytic leukemia), [MONDO:0020312](http://purl.obolibrary.org/obo/MONDO_0020312) (atypical chronic myeloid leukemia), [MONDO:0020115](http://purl.obolibrary.org/obo/MONDO_0020115) (secondary polycythemia), [MONDO:0020511](http://purl.obolibrary.org/obo/MONDO_0020511) (precursor b-cell acute lymphoblastic leukemia), [MONDO:0004967](http://purl.obolibrary.org/obo/MONDO_0004967) (acute lymphoblastic leukemia (disease)), [MONDO:0019460](http://purl.obolibrary.org/obo/MONDO_0019460) (acute leukemia of ambiguous lineage), [MONDO:0007896](http://purl.obolibrary.org/obo/MONDO_0007896) (acute monocytic leukemia), [MONDO:0020076](http://purl.obolibrary.org/obo/MONDO_0020076) (myeloproliferative neoplasm), [MONDO:0005571](http://purl.obolibrary.org/obo/MONDO_0005571) (polycythemia), [MONDO:0015667](http://purl.obolibrary.org/obo/MONDO_0015667) (unclassified acute myeloid leukemia), [MONDO:0013667](http://purl.obolibrary.org/obo/MONDO_0013667) (myelodysplastic syndrome), 

**Corr. equiv. classes:** [Orphanet:86839](http://www.orpha.net/ORDO/Orphanet_86839), [OMIM:187950](http://purl.obolibrary.org/obo/OMIM_187950), [Orphanet:238536](http://www.orpha.net/ORDO/Orphanet_238536), [OMIM:151380](http://purl.obolibrary.org/obo/OMIM_151380), [OMIM:601977](http://purl.obolibrary.org/obo/OMIM_601977), [Orphanet:85443](http://www.orpha.net/ORDO/Orphanet_85443), [Orphanet:86830](http://www.orpha.net/ORDO/Orphanet_86830), [Orphanet:86851](http://www.orpha.net/ORDO/Orphanet_86851), [Orphanet:247511](http://www.orpha.net/ORDO/Orphanet_247511), [Orphanet:67038](http://www.orpha.net/ORDO/Orphanet_67038), [Orphanet:3318](http://www.orpha.net/ORDO/Orphanet_3318), [Orphanet:519](http://www.orpha.net/ORDO/Orphanet_519), [Orphanet:98836](http://www.orpha.net/ORDO/Orphanet_98836), [Orphanet:518](http://www.orpha.net/ORDO/Orphanet_518), [Orphanet:167714](http://www.orpha.net/ORDO/Orphanet_167714), [Orphanet:514](http://www.orpha.net/ORDO/Orphanet_514), [OMIM:254500](http://purl.obolibrary.org/obo/OMIM_254500), [Orphanet:318](http://www.orpha.net/ORDO/Orphanet_318), [Orphanet:71493](http://www.orpha.net/ORDO/Orphanet_71493), [Orphanet:513](http://www.orpha.net/ORDO/Orphanet_513), [Orphanet:98274](http://www.orpha.net/ORDO/Orphanet_98274), [Orphanet:99860](http://www.orpha.net/ORDO/Orphanet_99860), [Orphanet:98277](http://www.orpha.net/ORDO/Orphanet_98277), [Orphanet:238547](http://www.orpha.net/ORDO/Orphanet_238547), [Orphanet:86846](http://www.orpha.net/ORDO/Orphanet_86846), [OMIM:601626](http://purl.obolibrary.org/obo/OMIM_601626), [Orphanet:29073](http://www.orpha.net/ORDO/Orphanet_29073), [OMIM:614286](http://purl.obolibrary.org/obo/OMIM_614286), [OMIM:113970](http://purl.obolibrary.org/obo/OMIM_113970), [OMIM:254450](http://purl.obolibrary.org/obo/OMIM_254450), [OMIM:614521](http://purl.obolibrary.org/obo/OMIM_614521), [Orphanet:98848](http://www.orpha.net/ORDO/Orphanet_98848), [Orphanet:168956](http://www.orpha.net/ORDO/Orphanet_168956), [Orphanet:98823](http://www.orpha.net/ORDO/Orphanet_98823), [Orphanet:98427](http://www.orpha.net/ORDO/Orphanet_98427), [Orphanet:98824](http://www.orpha.net/ORDO/Orphanet_98824), [Orphanet:98428](http://www.orpha.net/ORDO/Orphanet_98428), [Orphanet:824](http://www.orpha.net/ORDO/Orphanet_824), [OMIM:608232](http://purl.obolibrary.org/obo/OMIM_608232), [Orphanet:521](http://www.orpha.net/ORDO/Orphanet_521), [Orphanet:543](http://www.orpha.net/ORDO/Orphanet_543), [Orphanet:314962](http://www.orpha.net/ORDO/Orphanet_314962), 

**Class expressions from DL-Learner:**

- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma))) 46.26%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology))) 45.62%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face))) 43.89%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000234](http://purl.obolibrary.org/obo/HP_0000234) (Abnormality of the head))) 43.89%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000152](http://purl.obolibrary.org/obo/HP_0000152) (Abnormality of head or neck))) 43.89%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract))) 43.37%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0011843](http://purl.obolibrary.org/obo/HP_0011843) (Abnormality of skeletal physiology))) 41.67%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0005528](http://purl.obolibrary.org/obo/HP_0005528) (Bone marrow hypocellularity))) 40.40%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0002039](http://purl.obolibrary.org/obo/HP_0002039) (Anorexia))) 40.40%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000163](http://purl.obolibrary.org/obo/HP_0000163) (Abnormality of the oral cavity))) 40.36%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000498](http://purl.obolibrary.org/obo/HP_0000498) (Blepharitis))) 40.11%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 39.03%
- [HP:0010987](http://purl.obolibrary.org/obo/HP_0010987) (Abnormality of cellular immune system) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 38.54%
- [HP:0001881](http://purl.obolibrary.org/obo/HP_0001881) (Abnormality of leukocytes) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 38.54%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and [HP:0010987](http://purl.obolibrary.org/obo/HP_0010987) (Abnormality of cellular immune system) 37.43%


